2016 Research Articles
Causes/Risk Factors
- Small Intestine Bacterial Overgrowth and Environmental Enteropathy in Bangladeshi Children. PMID: 26758185
- The Effects of Total Colectomy on Bacterial Translocation in a Model of Acute Pancreatitis. PMID: 26730036
- Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling. PMID: 26660537
- Prevalence and treatment of small intestinal bacterial overgrowth in postoperative patients with colorectal cancer. PMID: 27123301
- High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. PMID: 27444134
- Functional 13C-urea and glucose hydrogen/methane breath tests reveal significant association of small intestinal bacterial overgrowth in individuals with active Helicobacter pylori infection. PMID: 27586816
- Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children. PMID: 28030512
- Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage. PMID: 7402085
Associated Conditions
- Association between small intestinal bacterial overgrowth and deep vein thrombosis. PMID: 27044499
- Etiopathogenesis of rosacea: a prospective study with a three-year follow-up. PMID: 26889725
- Rosacea and gastrointestinal disorders - a population-based cohort study. PMID: 27501017
- Association between rosacea and gastrointestinal disorders. PMID: 27603953
- Difficult case of Cronkhite-Canada syndrome with small intestinal bacterial overgrowth, Clostridium difficile infection and polymyalgia rheumatica. PMID:26818813
- Consequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric Surgery. PMID: 27576576
- Macronutrient intakes in obese subjects with or without small intestinal bacterial overgrowth: an alimentary survey. PMID:
26375876 - Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity. PMID: 26833719
- Small intestinal bacterial overgrowth in adult patients with type 1 diabetes: its prevalence and relationship with metabolic control and the presence of chronic complications of the disease. PMID: 27535109
- Higher visceral to subcutaneous fat ratio is associated with small intestinal bacterial overgrowth. PMID: 27282099
- Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. PMID:26554916
- Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model. PMID: 26754178
- Identification and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea. PMID: 26867023
- The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. PMID: 27279853
- Gut microbiota and non-alcoholic fatty liver disease. PMID: 26663004
- Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. PMID:
26212089 - Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. PMID: 27367724
- Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease. PMID: 27308646
- Prevalence of Small Intestinal Bacterial Overgrowth among Chronic Pancreatitis Patients: A Case-Control Study. PMID: 27446865
- Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis. PMID: 27733912
- Is irritable bowel syndrome an infectious disease? PMID: 26819502
- Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage. PMID: 7402085
- Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. PMID: 27379166
- [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin]. PMID: 27373356
- Motility Evaluation in the Patient with Inflammatory Bowel Disease. PMID: 27633599
- Is it bowel-associated dermatosis-arthritis syndrome induced by small intestinal bacteria overgrowth? PMID: 27652124
- Ischemia/Reperfusion Injury Alters Sphingolipid Metabolism in the Gut. PMID: 27607915
- Utility of wireless motility capsule and lactulose breath testing in the evaluation of patients with chronic functional bloating. PMID: 27648298
- Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. PMID: 28013205
- Prevalence of small intestinal bacterial overgrowth in Multiple Sclerosis: a case-control study from China. PMID: 27890460
- Association between small intestinal bacterial overgrowth and deep vein thrombosis in patients with spinal cord injuries. PMID: 27930853
- Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. PMID: 28013205
- Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease. PMID: 27589873
Testing
- Breath Testing for Small Intestinal Bacterial Overgrowth: Should We Bother? PMID: 26902227
- Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome. PMID: 26362282
- How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach. PMID: 26780631
- [Hydrogen Breath Tests]. German. PMID: 26886040
- Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome. PMID: 27331205
- Hydrogen Breath Testing With Measurement of Orocecal Transit for Diagnosis of Small Bowel Bacterial Overgrowth. PMID: 27094580
- Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS. PMID: 27163246
- Does Carbohydrate Challenge Testing Predict Clinical Response in Small Intestinal Bacterial Overgrowth? PMID: 27135726
- Refining small intestinal bacterial overgrowth diagnosis by means of carbohydrate specificity: a proof-of-concept study. PMID: 27134657
- Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico. PMID: 27681080
- Hydrogen Breath Testing With Measurement of Orocecal Transit for Diagnosis of Small Bowel Bacterial Overgrowth. PMID: 27094580
- Association between small intestinal bacterial overgrowth and deep vein thrombosis in patients with spinal cord injuries. PMID: 27930853
- Letter to the Editor: Small intestinal bowel gas and breath hydrogen after ingestion of lactulose.
Methane
Treatment
- How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach. PMID: 26780631
- Diagnosis and treatment of small intestinal bacterial overgrowth. PMID: 26636484
- Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation. PMID: 27650225
Treatment: Methane
- Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders. PMID: 26559904
- Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity. PMID: 26833719
- Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract (Atrantil). PMID: 27602249
Treatment: Herbal Antibiotics
- Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract (Atrantil). PMID: 27602249
Treatment: Antibiotics
- Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome. PMID: 26362282
- A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. PMID: 26731696
Treatment: Rifaximin
- Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. PMID: 26618924
- [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin]. PMID: 27373356
- Use of rifaximin in gastrointestinal and liver diseases. PMID: 27547007
- Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. PMID: 27662586
- Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition. PMID: 27560928
- Repeat Treatment With Rifaximin is Safe and Effective in Patients With Diarrhea-predominant Irritable Bowel Syndrome. PMID: 27528177
- Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. PMID: 27279570
- Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation. PMID: 27440420
Prokinetics
- The motilin receptor agonist erythromycin stimulates hunger and food intake through a cholinergic pathway. PMID: 26817505
Probiotics
- Poor predictive value of breath hydrogen response for probiotic effects in IBS. PMID: 26095068
- Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer. PMID: 27210778
- Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. PMID: 26908093
- Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. PMID: 26856749
- Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. PMID: 26914438
- Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. PMID: 27417338
- Challenges of Quantifying FODMAPs in Enteral Nutrition Formulas: Evaluation of Artifacts and Solutions. PMID: 27406943
- Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. PMID: 27382323
- Case Study: Utilizing a Low FODMAP Diet to Combat Exercise-Induced Gastrointestinal Symptoms. PMID: 27097380
- Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. PMID: 27099444
- Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. PMID: 27077959
- A low FODMAP diet in patients with Crohn's disease. PMID: 26990906
- Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. PMID: 26914438
- Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. PMID: 25982757
- Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. PMID: 27397586
- Editorial: gut-directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome? PMID: 27634230
- Editorial: gut-directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome? Authors' reply. PMID: 27634231
- A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. PMID: 27725652
- Restriction of FODMAP in the management of bloating in irritable bowel syndrome. PMID: 27664186
- Low FODMAP diet efficacy in IBS patients-what is the evidence and what else do we need to know? PMID: 27657161
- Managing irritable bowel syndrome: The low-FODMAP diet. PMID: 27618353
- Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. PMID: 27487397
- Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. PMID: 27747984
- Logical hypothesis: Low FODMAP diet to prevent diverticulitis. PMID: 27867683
- Case Study: Utilizing a Low FODMAP Diet to combat exercise-induced gastrointestinal symptoms. PMID: 27097380
- The cornerstone of dietary management for fructose intolerance is the individual reduction of fructose intake and the FODMAP diet, led by a trained dietetician. PMID: 27774805
- Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. PMID: 27747984
- A randomized controlled trial comparing the Low FODMAP Diet vs. Modified NICE Guidelines in U.S. adults with IBS-D. PMID: 27725652
If you value this website, consider supporting the free information provided on siboinfo.com and it's newsletter, which helps SIBO sufferers world wide.
Site author: Dr Allison Siebecker